Illness Patients Provider Seminar 
The Health Policy Exchange
MAY 20, 2013
Unfortunately, recent case studies have illustrated that FDA approval does not necessarily provide assurances of effectiveness and safety. Very quickly, the market included nearly all dialysis patients, not just the roughly 16 percent who required blood transfusions. The size of average doses would more than triple.
GeriPal
FEBRUARY 16, 2023
Summary Transcript Summary Think about the last time a patient yelled at you in anger. The last time this happened to me I immediately went on the defensive despite years of training in serious illness communication skills. Ask why: What is underneath the anger for this particular patient? Taking care of the hateful patient.
Expert insights. Personalized for you.
130 
Let's personalize your content